Pinnacle Financial Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-212
| Closed | -$223K | – | 527 |
|
|
2024
Q3 | $223K | Buy |
212
+18
| +9% | +$18.9K | ﹤0.01% | 418 |
|
|
2024
Q2 | $204K | Buy |
+194
| New | +$204K | ﹤0.01% | 431 |
|
|
2016
Q1 | – | Sell |
-960
| Closed | -$521K | – | 266 |
|
|
2015
Q4 | $521K | Buy |
960
+32
| +3% | +$17.4K | 0.16% | 149 |
|
|
2015
Q3 | $432K | Hold |
928
| – | – | 0.14% | 151 |
|
|
2015
Q2 | $473K | Hold |
928
| – | – | 0.15% | 143 |
|
|
2015
Q1 | $419K | Sell |
928
-577
| -38% | -$261K | 0.14% | 148 |
|
|
2014
Q4 | $617K | Hold |
1,505
| – | – | 0.22% | 119 |
|
|
2014
Q3 | $543K | Sell |
1,505
-290
| -16% | -$105K | 0.21% | 116 |
|
|
2014
Q2 | $507K | Hold |
1,795
| – | – | 0.2% | 118 |
|
|
2014
Q1 | $539K | Hold |
1,795
| – | – | 0.24% | 106 |
|
|
2013
Q4 | $494K | Sell |
1,795
-35
| -2% | -$9.63K | 0.23% | 108 |
|
|
2013
Q3 | $572K | Buy |
1,830
+250
| +16% | +$78.1K | 0.28% | 87 |
|
|
2013
Q2 | $355K | Buy |
+1,580
| New | +$355K | 0.18% | 96 |
|